Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy-Reference-Cited by-同舟云学术

Obesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy

Published:2005-10 Issue:2 Volume:122 Page:206-212
ISSN:0301-2115
Container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology
language:en
Short-container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology

Author:

Glueck Charles J.,Dharashivkar Swapna,Wang Ping,Zhu Binghua,Gartside Peter S.,Tracy Trent,Sieve Luann

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference38 articles.

1. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with polycystic ovary syndrome;Glueck;Metabolism,1999

2. Pregnancy outcomes among women with polycystic ovary syndrome;Glueck;Hum Reprod,2002

3. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy;Velazquez;Metabolism,1994

4. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7.

5. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome;Moran;J Clin Endocrinol Metab,2003

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome;The Journal of Clinical Endocrinology & Metabolism;2024-07-11

2. High-fat diet-negative impact on female fertility: from mechanisms to protective actions of antioxidant matrices;Frontiers in Nutrition;2024-06-10

3. Association of lipid profile and obesity in patients with polycystic ovary syndrome;Endocrine Regulations;2024-01-01

4. Polycystic ovary syndrome in North America;Polycystic Ovary Syndrome;2024

5. Gut microbiota and risk of polycystic ovary syndrome: Insights from Mendelian randomization;Heliyon;2023-12